Scholarly Index
Sho‐ichi Yamagishi
Showa University; 27,908 total citations; 492 total publications; best world rank #5
Showa University
27,908Total citations
492Total publications
86H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Natural Antidiabetic Agents Studies | Lifetime | 5 | JP 1 | 99.85 |
| Advanced Glycation End Products research | Lifetime | 27 | JP 1 | 99.50 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 48 | JP 1 | 99.43 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 80 | JP 2 | 99.24 |
| Alcohol Consumption and Health Effects | Lifetime | 159 | JP 3 | 98.40 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 277 | JP 4 | 98.96 |
| Chronic Kidney Disease and Diabetes | Lifetime | 181 | JP 11 | 98.91 |
| Diabetes Treatment and Management | Lifetime | 365 | JP 13 | 98.64 |
| Retinal Diseases and Treatments | Lifetime | 418 | JP 27 | 98.64 |
| Neutrophil, Myeloperoxidase and Oxidative Mechanisms | Lifetime | 208 | JP 5 | 97.93 |
| Atherosclerosis and Cardiovascular Diseases | Lifetime | 343 | JP 14 | 97.62 |
| Peroxisome Proliferator-Activated Receptors | Lifetime | 503 | JP 38 | 96.74 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 653 | JP 9 | 97.18 |
| Renin-Angiotensin System Studies | Lifetime | 573 | JP 62 | 95.14 |
| Advanced Glycation End Products research | 2021-2025 | 418 | JP 17 | 73.78 |